2023 Precision Oncology Patient Innovation Awards (POPIA)
Now Open for Worldwide Submissions
Bayer is proud to support the third global POPIA Awards, which are aimed to accelerate initiatives that are focused on improving access to precision oncology care and tackling inequalities for children with cancer around the world.
Apply for the Precision Oncology Patient Innovation Awards
Step 1: Download the application
Step 2: Submit a proposal
Important Date
June 16th, 2023 – Deadline for initial applications
About the Award
2 awards of $50,000 USD each will be awarded in 2023.
The awards are open to:
- 1 award to Non-governmental patient organizations.
- 1 award to Non-governmental healthcare institutions.
Applications from individuals will not be allowed.
This year’s program is focused on accelerating progress in biomarker testing and personalized care in childhood cancers. These cancers will have types of genomic alterations that can include mutations (e.g., KRAS, BRAF, EGFR), gene fusions (e.g., ROS1, NTRK, FGFR, RET), and many more.Successful applicants will be chosen by an independent, non-Bayer review panel from the cancer community.
Who Can Apply
Applications will be accepted from nonprofit organizations, including patient advocacy groups, educational institutions, and officially recognized healthcare/research facilities from around the world, unless prohibited by national law.
Applications from individuals will not be allowed.
Collaborations between institutions, including between patient groups and research facilities, are welcome.
Please designate a lead organization in the application.
